Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of “Hold” from Analysts

Certara, Inc. (NASDAQ:CERT) has received a consensus recommendation of “Hold” from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $17.08.

A number of research firms recently weighed in on CERT. UBS Group upgraded shares of Certara from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a research note on Friday, September 27th. KeyCorp dropped their price target on shares of Certara from $23.00 to $20.00 and set an “overweight” rating on the stock in a research note on Thursday, July 11th. Barclays dropped their price target on shares of Certara from $16.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday. JMP Securities reiterated a “market perform” rating on shares of Certara in a research note on Wednesday, July 10th. Finally, Robert W. Baird dropped their price target on shares of Certara from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 5,409 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $11.03, for a total transaction of $59,661.27. Following the transaction, the insider now directly owns 50,091 shares in the company, valued at approximately $552,503.73. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Patrick F. Smith sold 5,409 shares of the stock in a transaction on Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the completion of the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at $552,503.73. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction on Monday, September 9th. The stock was sold at an average price of $11.29, for a total value of $578,318.96. Following the sale, the insider now directly owns 99,704 shares of the company’s stock, valued at approximately $1,125,658.16. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.39% of the company’s stock.

Institutional Investors Weigh In On Certara

Several hedge funds have recently modified their holdings of the stock. Wasatch Advisors LP lifted its holdings in Certara by 23.4% in the first quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock valued at $88,056,000 after acquiring an additional 932,598 shares during the period. Daventry Group LP lifted its holdings in Certara by 153.0% in the second quarter. Daventry Group LP now owns 1,308,572 shares of the company’s stock valued at $18,124,000 after acquiring an additional 791,405 shares during the period. Geneva Capital Management LLC lifted its holdings in Certara by 15.1% in the first quarter. Geneva Capital Management LLC now owns 4,404,199 shares of the company’s stock valued at $78,747,000 after acquiring an additional 579,349 shares during the period. Kopion Asset Management LLC acquired a new stake in Certara in the third quarter valued at $4,457,000. Finally, Sei Investments Co. lifted its holdings in Certara by 39.5% in the second quarter. Sei Investments Co. now owns 997,871 shares of the company’s stock valued at $13,821,000 after acquiring an additional 282,357 shares during the period. 73.96% of the stock is owned by institutional investors and hedge funds.

Certara Stock Up 0.1 %

CERT stock opened at $11.22 on Thursday. The company’s 50 day moving average price is $11.67 and its 200 day moving average price is $14.48. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.61 and a current ratio of 2.61. Certara has a fifty-two week low of $10.35 and a fifty-two week high of $19.87. The firm has a market capitalization of $1.80 billion, a price-to-earnings ratio of -28.77, a PEG ratio of 5.40 and a beta of 1.49.

Certara (NASDAQ:CERT) last released its earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Certara had a positive return on equity of 3.03% and a negative net margin of 21.64%. The firm had revenue of $93.31 million for the quarter, compared to analysts’ expectations of $96.01 million. During the same quarter in the previous year, the company posted $0.10 earnings per share. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. On average, equities research analysts anticipate that Certara will post 0.27 EPS for the current fiscal year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.